New England Boasts More than $2 Billion in Second-Quarter 2016 Project Kickoffs, Led by Pharma

New England Boasts More than $2 Billion in Second-Quarter 2016 Project Kickoffs, Led by Pharma

New England Boasts More than $2 Billion in Second-Quarter 2016 Project Kickoffs, Led by Pharma


Attachment: New England Q216

SUGAR LAND--March 11, 2016--Researched by Industrial Info Resources (Sugar Land, Texas)--The New England region is looking at $2.02 billion worth of project kickoffs in second-quarter 2016, its highest quarterly total investment value (TIV) in a year, according to Industrial Info's project database. The growth is driven by pharmaceutical and biotech-related projects, which account for six of the 10 highest-valued projects, and the region's support for renewables, which has been a boon for wind energy. More than 90% of the total can be attributed to just three industries: Pharmaceutical & Biotech, Power and Industrial Manufacturing. Within this article: Details on major project kickoffs in New England slated for second-quarter 2016, including those from major companies such as FedEx Corporation (NYSE:FDX), Bristol-Myers Squibb Company (NYSE:BMY), Lonza Group, EDP Renewables North America LLC and Alnylam Pharmaceuticals Incorporated.

Subscribe Now!(All Fields Required)

Standard Membership - Free